Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma (CSAREA Study)

NCT05241769 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT05241769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05241769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic Asthma (CSAREA Study)
Lead sponsor
University Hospital Birmingham
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2022
Completion date
September 1, 2023
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma; eosinophilic